Limited Competition: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)
Funding Amount
Up to $2M
Deadline
Forecast — expected May 25, 2027
Forecast by the agency; not yet open
Number of Awards
6
Grant Type
Federal
Deadline history & next window
- Cycle
- Not stated
- Next expected
- May 25, 2027
- Tracked since
- September 2026
Forecast: expected to post March 25, 2027; applications expected due May 25, 2027.
Source: Grants.gov forecast for this opportunity.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Public colleges & universities
- Private colleges & universities
Other requirements
- Pursuant to Public Health Service Act section 464z-3(h), 42 USC 285t(h), as amended by Public Law 117-104, applicants for this program must include eligible public/private institutions of higher education that have current or former HRSA Centers of Excellence awards under Section 736 of the Public…
- Eligible institutions must have an endowment that is equal to or less than 50 percent of the national median of endowment funds at institutions that conduct similar biomedical research and training of health professionals.
Overview
As authorized under section 464z-3(h) of the Public Health Service Act, the purpose of the _John Lewis_ NIMHD Research Endowment Program is to strengthen the research infrastructure and training capacity at eligible institutions of higher education to facilitate health disparities research. Specific strategic objectives include: 1) improving the institutional physical infrastructure and acquisition of research equipment, 2) developing research-enabling technical expertise, 3) expansion of academic science programs relevant to scientific research, and 4) merit-based recruitment of highly accomplished researchers for open faculty positions. The _John Lewis_ NIMHD Research Endowment Program does not directly support research projects.
This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.
Full eligibility text
Pursuant to Public Health Service Act section 464z-3(h), 42 USC 285t(h), as amended by Public Law 117-104, applicants for this program must include eligible public/private institutions of higher education that have current or former HRSA Centers of Excellence awards under Section 736 of the Public Health Service (PHS) Act and current or former NIMHD Centers of Excellence awards under Section 464z-4 of the PHS Act. Eligible institutions must have an endowment that is equal to or less than 50 percent of the national median of endowment funds at institutions that conduct similar biomedical research and training of health professionals.
Focus Areas & Funding Uses
Fields of Work
- Health
Related Grants
Open grants from this funder and similar programs
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health
Amount
Varies
Deadline
October 6, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for Limited Competition: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Limited Competition: John Lewis NIMHD Research Endowment Program (S21 Clinical Trial Not Allowed). Now let's win it.